ESTROGEN REPLACEMENT THERAPY
\ˈɛstɹəd͡ʒən ɹɪplˈe͡ɪsmənt θˈɛɹəpi], \ˈɛstɹədʒən ɹɪplˈeɪsmənt θˈɛɹəpi], \ˈɛ_s_t_ɹ_ə_dʒ_ə_n ɹ_ɪ_p_l_ˈeɪ_s_m_ə_n_t θ_ˈɛ_ɹ_ə_p_i]\
Sort: Oldest first
-
The use of hormonal agents with estrogen-like activity in postmenopausal or other estrogen-deficient women to alleviate effects of hormone deficiency, such as vasomotor symptoms, dyspareunia, and progressive development of osteoporosis. This may also include the use of progestational agents in combination therapy.
By DataStellar Co., Ltd
Word of the day
Proto Oncogene Proteins c erbB 2
- cell surface protein-tyrosine kinase that is found to be overexpressed in significant number adenocarcinomas. It has extensive homology can heterodimerize EGF EPIDERMAL GROWTH FACTOR), 3 receptor (RECEPTOR, 3) and the 4 receptor. Activation of erbB-2 receptor occurs during heterodimer formation with a ligand-bound erbB family members. EC 2.7.11.-.